Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations. N Engl J Med. 2020 09 03; 383(10):931-943.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Edema
Exons
Female
Humans
Lung Neoplasms
Male
Middle Aged
Mutation
Piperidines
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-met
Pyridazines
Pyrimidines
authors with profiles
Marina Chiara Garassino